California

This week the Assembly passed SB 966, PBM Reform legislation. The bill returns to the Senate for concurrence with the Assembly amendments. The legislature will adjourn no later than midnight on August 31.

Also in California, the Department of Health Care Services posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal:

Also in California, effective for dates of service on or after September 1, 2024, the Department of Health Care Services has updated the List of Contracted Incontinence Creams and Washes.

Also in California, the Board of Pharmacy proposed the following rules:

Finally in California, the Board of Pharmacy’s Licensing Committee added an additional meeting on September 4, 2024, to continue its work on the Standard of Care Model. The agenda, meeting materials and written comments received were posted to the Board’s website.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-08-29T14:39:02-04:00August 29, 2024|California|

California

The Department of Health Care Services posted the following alerts, weekly notices and monthly bulletin on the Medi-Cal Rx Web Portal:

Also in California, this week, SB 966, PBM reform legislation, including provisions prohibiting the use of spread pricing, requiring 100% pass-through of manufacturer rebates to plan sponsors, and prohibiting the steering of patients to PBM-affiliated pharmacies, was placed on the Assembly Appropriations Committee suspense file and must be voted off the suspense file by August 16 to advance to the Assembly floor.

Finally in California, this week, the following bills were placed on the Senate Appropriations Committee suspense file and must be voted off the suspense file by August 16 to advance to the Senate floor:

  • AB 1794, legislation clarifying that the value of all property taken over the course of distinct but related acts may be aggregated even though the thefts occurred in different places or from different victims and authorizing counties to operate a program to allow retailers to submit details of alleged shoplifting, organized retail theft or grant theft directly to the county district attorney through an online portal to the district attorney’s internet website.
  • AB 82, legislation prohibiting a retail establishment from selling dietary supplements for weight loss or over-the-counter diet pills to any person under 18 years of age without a prescription. Amendments to the introduced language lowered the civil penalties from $1,000 to $250 for each violation and changed the effective date to January 1, 2026.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-08-08T08:30:41-04:00August 8, 2024|California|

California

NACDS submitted a letter to the Assembly Appropriations Committee in support of SB 966, PBM reform legislation, including provisions prohibiting the use of spread pricing, requiring 100% pass-through of manufacturer rebates to plan sponsors, prohibiting the steering of patients to PBM-affiliated pharmacies and requiring PBMs to obtain a license to operate in the state. 

Also in California, the Department of Health Care Services (DHCS) announced it will host its quarterly Hearing Aid Coverage for Children Program (HACCP) webinar for medical providers and hearing professionals on August 15 from 12:00 noon to 1:00 pm PDT. For more information and to pre-register, please visit DHCS’ HACCP webpage. 

Also in California, the Department of Health Care Services posted the following:  

Also in California, the Board of Pharmacy posted the agenda and meeting materials for the Full Board Meeting being held July 31-August 1. Please note the inclusion of compounding regulations. 

Finally in California, the Department of Health Care Services posted the following alert on the Medi-Cal Rx Web Portal: Reminder: Quantity Limit Restrictions for Anti-Obesity Preparations. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-07-25T10:26:10-04:00July 25, 2024|California|

California

2024-07-11T11:16:03-04:00July 11, 2024|California|

California

The Department of Health Care Servies posted the following weekly notice on the Medi-Cal Rx Web Portal: Medi-Cal Rx Weekly Wrap-up for June 14-20.

Also in California, as part of Gov. Gavin Newsom’s (D) Master Plan for Tracking the Fentanyl and Opioid Crises, California will make its own private label branded over the counter (OTC) naloxone hydrochloride (HCL) nasal spray (CalRx®). It will be available for free to eligible organizations through the California Department of Health Care Services (DHCS) Naloxone Distribution Project (NDP) or for sale for $24 per twin-pack. The state is also working on an option for individuals to buy CalRx OTC naloxone nasal spray directly.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-06-27T11:04:53-04:00June 27, 2024|California|

California

2024-06-20T10:23:35-04:00June 20, 2024|California|

California

2024-06-13T14:47:54-04:00June 13, 2024|California|

California

2024-06-06T16:08:45-04:00June 6, 2024|California|
Go to Top